Response and adherence to Nilotinib in daily practice (RAND-study): An in-depth observational study of patients with chronic myeloid leukemia treated with Nilotinib

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)125-126
JournalPharmacoepidemiology and Drug Safety
Volume28
Publication statusPublished - Aug 2019

Cite this

@article{c3a6e6e2ad98403cb903842e74c73b14,
title = "Response and adherence to Nilotinib in daily practice (RAND-study): An in-depth observational study of patients with chronic myeloid leukemia treated with Nilotinib",
author = "Boons, {Christel C. L. M.} and Lonneke Timmers and Janssen, {Jeroen J. W. M.} and Westerweel, {Peter E.} and Swart, {Eleonora L.} and Harry Hendrikse and Jacqueline Hugtenburg",
year = "2019",
month = "8",
language = "English",
volume = "28",
pages = "125--126",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Response and adherence to Nilotinib in daily practice (RAND-study): An in-depth observational study of patients with chronic myeloid leukemia treated with Nilotinib

AU - Boons, Christel C. L. M.

AU - Timmers, Lonneke

AU - Janssen, Jeroen J. W. M.

AU - Westerweel, Peter E.

AU - Swart, Eleonora L.

AU - Hendrikse, Harry

AU - Hugtenburg, Jacqueline

PY - 2019/8

Y1 - 2019/8

M3 - Meeting Abstract

VL - 28

SP - 125

EP - 126

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

ER -